Search
Searching Content from China indexed under Food, Drugs, Healthcare, Life Sciences ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
高值医用耗材"两票制"实操及应对探讨
2019年7月31日,国务院办公厅正式发布《治理高值医用耗材改革方案》(简称"《方案》"),标志着医改已全面深入到医疗器械领域。其中,高值医
China
18 Sep 2019
2
热议新版《药品管理法》:积极响应监管,把握行业机遇
此等问题的正解且待新药法实施细则和《药品注册管理办法》修订来澄清。
China
6 Sep 2019
3
进口未批的境外新药不按假药论处,但并非就是无罪
2019年8月26日,《药品管理法》经修订后通过,其中原法第三十九条第二款的"医疗单位临床急需或者个人自用进口的少量药品,按照国家有关规定
China
4 Sep 2019
4
OFAC Sanctions China-Based Drug Trafficking Organization
OFAC designated the China-based Zheng Drug Trafficking Organization ("Zheng DTO") and Chinese nationals Zheng Fujing and Yan Xiaobing
Worldwide
26 Aug 2019
5
改革动作频频,千亿医疗器械市场面临机遇和挑战
近几个月来医疗器械行业内改革动作频频。医疗器械注册人制度试点扩大到21个省,有如释放行业创新活力的一剂良方,监管方通过将产研分开&#
China
22 Aug 2019
6
China's Central Government Introduces Major Policy Incentives And Restraints To The MedTech Industry
After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
China
21 Aug 2019
7
京都所汤建彬律师辩护的河北省最大毒品案成功摘掉恶势力定性
近日,由京都律师事务所合伙人汤建彬律师承办的河北最大贩毒案由保定市中级
China
13 Aug 2019
8
汤建彬律师死刑复核辩护再传喜讯
于某某贩卖毒品死刑复核案,历时3年多,最高人民法院在充分
China
13 Aug 2019
9
汤建彬律师辩护泉州吴某某贩卖毒品案二审成功改判死缓
近日,北京市京都律师事务所合伙人汤建彬律师承
China
12 Aug 2019
10
远程医疗的法律概念和内容浅析
提出了"远程医疗会诊"的概念,远程医疗会诊是应用计算机及网络、通讯技术进行异地医疗咨询活动,属于医疗行为,必须在取得《医疗机构执&#
China
9 Aug 2019
11
医疗机构投资并购之法律尽职调查实务分析
在国家医疗体制改革、支持社会办医及医疗大健康产业飞速发展的背景下,医疗机构并购领域已成为传统医疗集团和各路产业资本(地产商、
China
8 Aug 2019
12
New Human Genetic Resources Regulations In China
On 28 May 2019, the People's Republic of China State Council promulgated the People's Republic of China Human Genetic Resources
China
23 Jul 2019
13
Chinese government releases new regulation on human genetic resources
Anyone who collects, preserves, utilizes or provides China's human genetic resources should comply with the regulations.
China
9 Jul 2019
14
China's State Council Publishes New Regulations On The Management Of Human Genetic Resources
China's State Council, the country's top administrative authority, released a new Regulation of Human Genetic Resources1 (the "Regulation") on May 28, 2019, to replace the tentative rules issued
China
26 Jun 2019
15
Survival Of The Fittest Or Cheapest?
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
China
4 Jun 2019
16
China Proposes Major Changes To Pharmaceutical Regulations
On April 20, 2019, the Chinese government submitted a second draft of the Drug Administration Law of the People's Republic of China to the Standing Committee of the NPC for deliberation.
China
30 May 2019
17
Generic Drugs
Supply of generic drugs and their interaction with the patent system, like standards essential patents, present one of the international frontiers of patent protection.
China
5 Mar 2019
18
China's SAMR Fines Hunan Er-Kang And Henan Jiushi CNY 10 Million For Unfair Pricing Of Chlorpheniramine API
On 30 December 2018, China's State Administration for Market Regulation (SAMR) issued an infringement decision imposing a total fine of CNY 10.04 million
China
5 Feb 2019
19
China Aims To Introduce Routine Drug And Device Overseas Inspections
China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies.
China
18 Jan 2019
20
Patenting Regenerative Medicine In China
Regenerative medicine, which aims at the process of replacing, engineering or regenerating human cells, tissues or organs, so as to restore or establish the normal function of a living organism ...
China
27 Nov 2018
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next